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Abstract
Background: Peptides are important molecules with diverse biological functions and biomedical
uses. To date, there does not exist a single, searchable archive for peptide sequences or associated
biological data. Rather, peptide sequences still have to be mined from abstracts and full-length
articles, and/or obtained from the fragmented public sources.
Description: We have constructed a new database (PepBank), which at the time of writing
contains a total of 19,792 individual peptide entries. The database has a web-based user interface
with a simple, Google-like search function, advanced text search, and BLAST and Smith-Waterman
search capabilities. The major source of peptide sequence data comes from text mining of
MEDLINE abstracts. Another component of the database is the peptide sequence data from public
sources (ASPD and UniProt). An additional, smaller part of the database is manually curated from
sets of full text articles and text mining results. We show the utility of the database in different
examples of affinity ligand discovery.
Conclusion: We have created and maintain a database of peptide sequences. The database has
biological and medical applications, for example, to predict the binding partners of biologically
interesting peptides, to develop peptide based therapeutic or diagnostic agents, or to predict
molecular targets or binding specificities of peptides resulting from phage display selection.  The
database is freely available on http://pepbank.mgh.harvard.edu/, and the text mining source code
(Peptide::Pubmed) is freely available above as well as on CPAN (http://www.cpan.org/).
Background
Peptides have emerged as important affinity ligands for
diagnostic and therapeutic medical uses as well as materi-
als for a host of applications in biotechnology. While
many excellent databases exist that provide protein
sequence data [1-3], protein interaction data [4-9], and
peptide data [10-13], a substantial fraction of literature
data remains untapped. Unfortunately, the wealth of the
peptide sequences in these sources is often difficult to
access by modern methods of sequence similarity search-
ing, because peptide sequences are not extracted in a suit-
able format. We therefore sought to address this issue by
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MEDLINE abstracts for peptide sequences, combining the
existing bioinformatics sources, and manually curating
the full text articles and MEDLINE text mining results. The
data, available through a web-based interface for simple
and more advanced text search and BLAST and Smith-
Waterman sequence similarity search, proved useful in
our own work. Examination of initial data yielded some
surprises as well, providing an incentive for us to make
further improvements to the database. We hope that the
peptide database, the associated tools, and the text mining
algorithm will be useful to the larger biomedical commu-
nity.
Peptides are defined by International Union of Pure and
Applied Chemistry and International Union of Biochem-
istry and Molecular Biology (IUPAC-IUB) as compounds
"produced by amide formation between a carboxyl group
of one amino acid and an amino group of another" [14].
In this paper, we use the term "peptides" as a common
synonym for oligopeptides, which are defined as having
"fewer than about 10–20 residues"[14]. We thus currently
use an IUPAC-IUB length cut-off of 20 amino acid resi-
dues or less. Many of the peptides used as pharmaceutical
and diagnostic agents fall within this cut-off.
Naturally occurring peptides function as hormones, trans-
mitters, and modulators of numerous biological processes
[15]. Both naturally occurring and synthetic peptides are
used in therapeutic applications [15], for example soma-
tostatin analogs in tumor radiotherapy [16,17] and oxy-
tocin to induce labor [18]. Examples of diagnostic uses
include membrane-translocating agents [19], receptor tar-
geting agents [20], and enzyme substrates [21]. Driven by
the great interest in the diverse applications of peptides,
the new peptidomics field is rapidly emerging [22]. The
functions of peptides, including their interacting partners,
are determined by their sequence and similar to longer
proteins, can be predicted based on sequence similarity.
Prior knowledge can be used to predict or shorten the list
of possible binding partners of a given peptide of interest,
provided a peptide shares significant sequence similarity
with other peptides or proteins whose binding partners
are known [20,23]. One can also use a sequence similarity
search to remove peptides with similarity to other pep-
tides with known, undesirable properties such as non-spe-
cific binding [24] or toxicity. Computational predictions
are relatively fast and inexpensive, but require a peptide
sequence database with links to peptide data, for use with
sequence similarity search methods such as basic local
alignment search tool (BLAST) [25,26] or Smith-Water-
man search [27,28]. The non-sequence (text) data in such
a peptide database can be queried with text search tools
for biological, therapeutic or diagnostic applications, for
example to find peptides that are enzyme inhibitors and
whose sequences are available.
We searched through the existing bioinformatics sources,
and found no single source that fully suited our needs.
With the exception of the Receptor Ligand Contacts
(RELIC) database and web-server [10] and Artificially
Selected Proteins/Peptides Database (ASPD) [11], most
large protein sequence and interaction databases that
allow both sequence similarity and text annotation
searches have two major drawbacks. First, most of their
sequences are of biological origin, while many phage dis-
play [29,30] or combinatorial screens yield non-biologi-
cal sequence hits. There is no large repository of
chemically generated unnatural sequences, similar to
what PubChem [2] or ChemBank [31] are for com-
pounds. Second, there exists less data on short peptides
than on longer proteins, and usually no facile way to
restrict the search to short sequences only. This is impor-
tant because performing an unrestricted sequence similar-
ity search often results in a large proportion of false
positives due to hits to proteins in which the peptide
sequence is buried and not accessible for binding, or is in
a conformation different from that in a shorter peptide.
The same sequence may have different binding properties
when displayed on a phage versus when presented as part
of the native protein [32]. Sequence similarity based pre-
dictions are further hampered for conformationally con-
strained peptides, designed specifically to have properties
different from the same sequence in linear form [33].
ASPD [11] and RELIC [10] databases do not have these
drawbacks, are well curated, but are relatively small com-
pared with the large amount of sequence data in the
MEDLINE abstracts. For example, the ASPD database has
1,717 entries of 20 amino acid or shorter sequences.
RELIC (a server with many useful peptide sequence anal-
ysis tools) has 3,632 peptide sequences that result from
phage display selections, but only 7 distinct targets to
which they bind. Other peptide databases have different
purposes and are more specialized by design, for example
antimicrobial (the Antimicrobial Peptide Database (APD)
[13], and others [12,34,35]), phosphorylation sites (Scan-
site [36]), or major histocompatibility complex related
(SYFPEITHI [37], EPIMHC [38], and others [39-42]).
In order to create a database suitable for the identification
of affinity ligands, we developed text mining methods to
extract peptide sequences from MEDLINE abstracts and
compiled them in a single, easily searchable database.
While far from complete, the database is a useful publicly
available source of peptide sequences and the associated
data. Below we show how the database was constructed,
how it functions, and how it can be used to identify target-
ing ligands.Page 2 of 10
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Database model and overview
The database model (Figure 1) was adopted from the Pro-
teomics Standards Initiative Molecular Interactions (PSI
MI) model for storage of biological interactions [43] and
was extended to facilitate secure access to curate entries.
Each entry is associated with a "peptide sequence", an
"interactor", an "experiment" and a "group". The group
serves to assign user permissions for curating entries. Sep-
arate tables, which are not shown for clarity, define con-
trolled vocabularies. These were adopted where possible
from the existing ontologies. Organism vocabulary used
for peptides, interactors and interactions was adopted
from the National Center for Biotechnology Information
(NCBI) Taxonomy [2]. The detection method vocabulary,
utilized for experiments, was adopted from PSI MI ontol-
ogy using the descendants of the term MI:0001, "interac-
tion detection method".
The application is using the open source Ruby on Rails
framework [44] with a MySQL database [45] in the back-
end. The BLAST search [25,26] was implemented using
the NCBI binaries [46]. The Smith-Waterman search was
implemented using the SSEARCH program from the
FASTA3 distribution [27,28,47]. The databases for
sequence similarity searches included, in addition to
sequences, the motifs, with any variable positions
replaced with X for simplicity (for example, motif 'P(P/
S)GH(Y/F)K' was used as 'PXGHXK').
The database was constructed from the following sources
(with the current number of entries in parentheses): text
mining of MEDLINE abstracts (13,596 entries), manual
curation of full text PDF articles (859), and other public
sources: ASPD (1,717) and UniProt (3,620), as described
in the sections below. The total number of entries is cur-
rently 19,792. A small fraction of the peptide sequences
resulting from MEDLINE abstract text mining were manu-
ally curated: 1,773 entries were validated as correct pep-
tide sequences, and 170 of those were more fully
annotated with additional interaction data present in the
abstract. The database continues to grow as the new data
are added to the sources such as MEDLINE and UniProt.
MEDLINE abstract text mining
In order to identify abstracts with peptide sequences, the
entire MEDLINE database with its 15 million records was
downloaded from the National Library of Medicine
(NLM) ftp site [48]. The text mining code was written in
Perl, a language selected due to its text processing capabil-
ities, and widely used in many important biomedical lit-
erature text mining applications [49-51]. Data were
processed in 3 steps. First, each abstract was assigned a
score based on how likely it was to contain a peptide
sequence anywhere within the text. Second, each individ-
ual word was assigned a score based on how likely it was
to contain a peptide sequence. For each word, a combined
score was then computed based on both the word score
and the abstract score. Thus, in total, we used three types
of scores (abstract, word, and combined). Third, the
sequences associated with the words were cleaned, and
ambiguities resolved. After these tasks were completed,
the words were ranked by the combined score and
included in the peptide database based on empirically
determined thresholds. Each unique sequence per abstract
identified by text mining was assigned one database entry.
Multiple occurrences of the same sequence in different
forms, such as 'RGD' and 'Arg-Gly-Asp', were considered a
single entry.
Text mining was performed on a Fedora Core 5 Linux vir-
tual machine running on an HP DL320 server with two 3
GHz Xeon processors, allocated 512 MB of RAM. The data
resided on a file server connected via Gigabit Ethernet.
Text mining of the entire MEDLINE (baseline distribution
and updates) took 44 hours, with an additional 16 hours
for pre-processing: downloading, uncompressing/com-
pressing and parsing MEDLINE distribution files. The
resulting database was 35 MB. Incremental weekly
processing of MEDLINE updates took on average under 1
hour.
Step 1. Classification of abstracts
MEDLINE entries that were either duplicates, or did not
have abstracts, or were older than 1950 were removed.
The older abstracts, which were published prior to the
development of Edman degradation [52], did not contain
peptide sequences. Several pattern categories of interest
were created, such as those related to peptides, phage dis-
play, proteases, and others. For each abstract, the total
number of matches to patterns in each category was com-
puted, for example, for the 'peptide' category this included
the number of matches to 'peptid' or 'hormone', and if at
least one of these patterns was present, additionally
included the number of matches to less specific patterns
such as 'sequenc' or 'motif'. The title, abstract, medical
subject heading terms and the chemical list were all
scored. Some of the abstracts, especially those published
before mid-1990s, often include peptide sequences which
are related to protein digestion and sequencing. These
sequences usually represent parts of longer proteins,
rather than individual peptides, and were thus scored dif-
ferently. Any matches to this 'digestion' category of pat-
terns were counted. The abstract score was computed as
the sum of the number of matches to categories 'peptide'
and 'phage', minus the number of matches to the 'diges-
tion' category. Additional terms were added to the abstract
score for matches to more than one pattern category in the
same abstract, for example the number of matches to pat-
terns from the 'phage' category multiplied by the numberPage 3 of 10
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tides, such as those selected using the oriented phos-
phopeptide library technique [53], were not scored any
differently from other peptides, that is, neither included
not excluded specifically. There is a useful resource, Scan-
site, dedicated specifically to the phosphorylated peptides
[36], which can be used for this application. Texts with a
large number or fraction of words in all caps tend to pro-
duce many false positives, thus the abstract score was
decreased for such abstracts. The abstract score was then
transformed for convenience to the (0,1) interval using
the function: y = x/(1+x). An abstract score below 0 was
assigned to 0. An abstract related to peptide sequences
tended to have a score close to 1, and an unrelated one to
0.
Step 2. Classification of words
Each abstract was split into words on whitespace. Each
word was matched against a series of peptide sequence
pattern categories, in order of decreasing specificities of
patterns, until the first successful match. The pattern cate-
gories were: full names of amino acids (longest, most spe-
cific, such as 'valine' or 'valyl'), 3 letter symbols (such as
'Val') and 1 letter symbols (such as 'V', least specific).
Because the recommendations of IUPAC-IUB for report-
ing peptide sequences [14] were not followed in a large
number of abstracts, we had to use a complex classifica-
tion method and added methods to clean sequences and
resolve the ambiguities. Any word that matched a pattern
of peptide sequence of at least two amino acids was
assigned a score. The score was an empirically calculated
measure used to distinguish peptide sequences from other
terms, such as nucleic acid sequences, gene symbols, acro-
nyms and all caps English words, which they sometimes
closely resemble or are even identical to, when taken out
of context.
The above score was defined by several factors. The
length/amino acid symbol factor was based on the length
of the sequence in amino acids (higher score for longer
sequence patterns, which were more specific) and on the
type of amino acid symbols used (higher score for the
more specific full names than for 1 letter symbols). The
degenerate amino acid factor was based on the fraction
and the total number of degenerate amino acids (lower
score for degenerate amino acids such as 'X' or 'Xaa',
which may represent, for example, the starting rand-
omized phage display library rather than the selected pep-
tide). Other factors reflected similarity to either of the
following categories: Roman numerals, nucleic acid
sequences, gene names and gene symbols, English words,
scientific terms or abbreviations, or a combination of the
above. The list of abbreviations was derived from the com-
prehensive ADAM database [54]. The list of gene names
and symbols was derived from Entrez Gene [55], UniProt
[1] and Human Gene Nomenclature (HGNC) [56] data-
bases. An additional factor represented similarity of a
given word to protein sequences relative to English words.
It was computed for all words that matched a pattern of
sequences in 1 letter amino acid symbols. The word was
broken up into overlapping k-mers. For example, for k =
3, word 'EYHHYNK' was broken up into 'EYH', 'YHH',
'HHY', 'HYN', 'YNK'. The proportions of all possible k-
mers were precomputed in the databases of known pro-
tein sequences (from UniProt) and non-sequences (here,
English words from MEDLINE abstracts not related to
peptides), designated Pp and Pn, respectively. We used the
databases of protein sequences and non-sequences of 8 ×
107 k-mers each, with k = 3, replacing counts of 0 with 1
to avoid division by 0. The protein/English word similar-
ity factor was defined as the product over all overlapping
k-mers within the word of (Pp/Pn). For a word with all k-
mers equally frequent among sequences and non-
sequences, the factor was 1, while for a word such as 'EYH-
HYNK' in which on average the k-mers were more fre-
quent in protein sequences than in English words, the
factor was greater than 1.
The word score was transformed to the (0,1) interval, sim-
ilarly as in the abstract score. The word score thus
depended only on the properties of the word itself, rather
Database core modelFigure 1
Database core model. MySQL tables are shown as rectan-
gles. Mandatory attributes are in bold, optional are in italics. 
Relationships are shown as lines, with the arrows pointing 
from the primary to the foreign keys, and multiplicities as 
shown.Page 4 of 10
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combined word/abstract score was then computed for
each word, and reflected the abstract score, the word
score, and the maximum word score for all words in the
abstract, included because sequences tend to occur
together in abstracts. The combined word/abstract score sc
was computed according to the formula
sc = sa(w1sw + w2sm), for sw > 0,
sc = 0, for sw = 0,
where sa is the abstract score, sw is the word score of the
current word, sm is the maximum word score for all words
in the abstract, and w1, w2 are the weights (w1 > w2). The
combined score varied in the (0,1) interval. Words that
matched peptide sequence patterns in abstracts related to
peptides tended to have a score close to 1, and close to 0
otherwise.
Step 3. Clean-up
Words that matched peptide sequence patterns were
cleaned in a series of steps and converted to 1 letter amino
acid symbols, as follows. The terminal marks and modifi-
cations, such as 'H(2)N-' or '-CO-Ph', were removed.
Numbers representing amino acid positions were
removed. Other modifications, such as phosphate in 'pY'
were removed. Motifs such as '(L/I)' or 'L/I' were resolved.
Amino acids that do not have a 1 letter IUPAC symbol
were replaced with X. As a result, a large variety of different
sequence formats were resolved, including 'N-acetyl-l-
aspartyl-l-glutamyl-l-valyl-l-aspartyl-7-amino-4-methyl-
coumarin' to 'DEVD', 'Gly1-Val2-Thr3-Ser4' to 'GVTS',
'(Arg-Glu(EDANS)-Ser-Gln)' to 'RESQ', 'TRDI-pY-ETD-
pY-pY-RK' to 'TRDIYETDYYRK', and others.
To estimate precision of text mining, 50 sequences with
the combined score above the threshold for inclusion in
PepBank were selected at random from the text mining
output. Each of these positive predictions was manually
verified, whether or not the word contained a peptide
sequence (40 out of 50 were found correctly, precision =
0.8), and whether or not the word contained a peptide
sequence AND the sequence was parsed 100% correctly
(35 out of 50 correct, precision = 0.7). If the identified
sequence was a partial protein sequence, rather than a
peptide or a phage display sequence, it was considered an
error: such sequences are typically entered in protein data-
bases and do not need to be mined from text (most of the
errors in precision were of this type). One or more incor-
rect amino acid was also considered an error.
For estimating recall, we created a separate test set of 50
sequences by searching in PubMed for recent review arti-
cles using as a query "peptide OR peptides" alone or in
combination with "sequence OR sequences", and fol-
lowed the PubMed abstract links for the references cited in
the reviews. Peptide sequences were manually extracted
from the abstracts without any automated pattern match-
ing. The text mining output with the combined score
above the threshold for inclusion in PepBank was
matched against these positive real cases. Again, for each
case we manually verified whether or not the algorithm
found the word, which contained this peptide sequence
(12 out of 50 correct, recall = 0.24), and whether or not
the algorithm found the word AND the sequence was
parsed 100% correctly (10 out of 50 correct, recall = 0.2).
Most of the errors in recall were due to blanks (often
typos) inside peptide sequences or due to unrecognized
amino acid modifications.
The pioneering method to identify DNA and protein
sequences in text, based on Markov models was described
by Wren and co-workers [57]. Our text mining method,
while similar in spirit, has different goals and thus uses a
different sequence identification strategy. One of our
main goals was to rapidly identify peptides with potential
therapeutic and diagnostic utility (including those derived
from phage display peptides), rather than identifying pep-
tide epitopes and providing an aid to their manual cura-
tion. We also use extensive context information from the
abstract, and collect peptide motifs in addition to
sequences. We clean the sequences and provide access to
the data for biologists through a simple web-based inter-
face for text and sequence similarity searches. We do not
place a minimum length restriction on sequences, such as
6 amino acids, because many therapeutic peptides are rel-
atively short, for example the well-known RGD motif and
many others found in phage display. Due to the substan-
tial differences in goals and methods between our
approach and that of others, it may be interesting to
develop in the future a hybrid method combining the
strengths of both approaches.
Other sources
All peptide sequences with length 20 or below were
extracted from ASPD [11] and UniProt [1], and fields that
mapped to PepBank were parsed and stored (for example,
interactor fields from ASPD, peptide fields from UniProt).
The links from PepBank to the source databases were pro-
vided for all entries. Many of the peptides were stored in
UniProt as part of the longer precursor proteins, produc-
ing peptides on cleavage. These peptide sequences were
extracted using the UniProt feature table by selecting
those with feature key "peptide" or "chain" and feature
length under 20. Additional entries were manually
curated, capturing the available interaction data, from the
full text articles on phage display in PDF format. The arti-
cles were chosen to represent a small but diverse selection
of reports within this field.Page 5 of 10
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User interface
The web-based user interface to PepBank offers text search
(both Quick and Advanced), as well as sequence similar-
ity search (BLAST and Smith-Waterman algorithms). The
Quick Search function offers a simple, Google-like search
for biologists looking for peptide data in all fields.
Advanced Search options include querying data by indi-
vidual fields. Exact search, wildcard (*) and any single
character (_) are supported in text search, which enables,
for example, searching for a sequence pattern as a query.
The results of the text search are displayed as a table sort-
able in the browser, with hyperlinks to the original
sources (MEDLINE/PubMed, ASPD, UniProt) and to
more detailed information.
Text search example: VEGFR related peptides
To illustrate the utility of PepBank, we use the example of
identifying peptides with affinity to VEGFR1, an impor-
tant therapeutic target [58]. The user can search for VEGFR
using either Quick or Advanced Search, obtain a set of
peptide sequences related to this target, and view details
for the selected sequences. In the example shown in Figure
2, sequence 'WHSDMEWWYLLG' is identified [59].
Prompted by these results, the user of PepBank may be
interested in testing this peptide sequence in novel forms
(for example, dendrimers, or conjugated to nanoparti-
cles), or for novel biomedical applications (imaging dif-
ferent tumor types, atherosclerosis, or arthritis). There is
currently no database where the user can easily obtain
such information as it relates to molecular targets and
peptide sequences. One can also query directly for a bio-
logical process (such as apoptosis or angiogenesis) or for
the target cell line or tissue (such as BICR-H1 or U937).
To determine whether the database would yield target
leads against known drug targets, we randomly chose a set
of 20 defined drug targets from the 547 approved drug tar-
get data set in DrugBank [60]. The randomly chosen drug
targets were not skewed towards peptide receptors and
included: squalene epoxidase, RAF proto-oncogene ser-
ine/threonine-protein kinase, muscarinic acetylcholine
receptor M4, opioid mu receptor (OP3), adenosine A1
receptor, GABA transaminase, amidophosphoribosyl-
transferase precursor, tryptophan 5-hydroxylase 1, apop-
tosis regulator Bcl-2, matrix protein M2, vascular
endothelial growth factor receptor 2 precursor, amiloride-
sensitive sodium channel gamma-subunit, ribonucleotide
reductase, cAMP phosphodiesterase, coagulation factor
VIII, high affinity immunoglobulin epsilon receptor
alpha-subunit precursor, retinol-binding protein I, glycine
alpha 2 receptor, cytochrome P450 51, GABA-A receptor
subunit (C. elegans). Relevant peptides were defined as
those interacting with the target or its ortholog, or modu-
lating the function of the target, for example by acting as
a competitor. Relevant peptides in our database were
identified in approximately 25% of the above drug targets.
Sequence similarity search examples
As an illustrative example, we performed an all-against-all
BLAST search of PepBank sequences. One of the surprises
was the discovery of an exact match to sequence
'GETRAPL' from phage display selection for peptides that
bind to secreted protein acidic and rich in cysteine
(SPARC) [61]. The sequence had a BLAST hit with an E-
value of 0.06 to an isolate from phage display selection of
peptides that bind human saphenous vein smooth muscle
cells [62]. Following the BLAST results, we then found that
in addition to these 2 selections, the exact same sequence
was isolated independently multiple times by different
groups in selections with unrelated targets. GETRAPL was
found in phage display selections of peptides that bind
human immunodeficiency virus type 1 (HIV-1) accessory
viral protein (Vpr) [63], chromatin high mobility group
protein 1, box A (HMGB1) from rat [64], mouse skeletal
muscle tissue in vivo [65], and mouse brain cells in vivo
[66].
We suggest that one of the utilities for PepBank is to
search the peptide sequences of interest to the user with
BLAST or Smith-Waterman algorithms to find any impor-
tant similarities to the known peptides collected in our
database. In this example, the search can be used to
remove a relatively nonspecific binder GETRAPL. Note
that searching PepBank with these tools is a unique
resource: an exact match may be easy to find, but using a
partial match such as GETRA as a query finds GETRAPL
only in PepBank, but not in PubMed [2] or on Google.
Searching with BLAST [67] or with Smith-Waterman/
SSEARCH methods [47] using GETRAPL as a query
against nr database [2] gives no peptide hits cited above.
A large interactions database IntAct [6] gives no hits for
GETRAPL query at all.
Another surprise discovery in the all-against-all BLAST
search of PepBank sequences was the multiple occurrence
of the sequence SVSVGMKPSPRP. The sequence had sev-
eral exact matches over its entire length of 12 amino acids,
with an E-value of 1 × 10-6. It was isolated in phage display
selection for peptides that bind to DNA [68]. In this selec-
tion SVSVGMKPSPRP was the only sequence studied due
to its dominance (9 out of 10) in the selected pool. The
exact same sequence was isolated in phage display selec-
tion for peptides binding to human monoclonal IgM [69],
and to the mirror image of Alzheimer's disease amyloid
peptide Abeta(1–42) [70]. The sources for these
sequences were MEDLINE abstract text mining, ASPD
database, and manually curated full text articles, respec-
tively. In addition, SVSVGMKPSPRP occurs in several pat-
ents [71,72]. Several groups note multiple isolation of thisPage 6 of 10
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experiments [73,74]. The sequence has also been identi-
fied in a recent excellent review [24] which covers the
important topic of target-unrelated sequences in phage
display. Interestingly, all of the studies with both
GETRAPL and SVSVGMKPSPRP were done with the phage
display libraries from the same manufacturer, thus sug-
gesting a library- or methodology-specific phenomenon.
Both sequences illustrate one of the suggested utilities for
PepBank, namely that one can search it with a sequence
Web-based user interface of PepBankFigure 2
Web-based user interface of PepBank. Illustration of a typical user workflow. The user enters the query with Quick or 
Advanced Search. The results are returned in a table sortable in the browser. The user selects the entry or entries of interest. 
The sequence in the example shown was obtained by text mining and was then manually curated. The score, between 0 and 1, 
reflects the degree of confidence in the interaction (higher score for more confidence). Manually curated entries receive higher 
score than entries from automated text mining.Page 7 of 10
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any important similarities to the known peptides.
Conclusion
A new text mining tool was developed and used to iden-
tify peptide sequences in MEDLINE abstracts. These data
were combined with two of the public sources of peptide
sequence data, ASPD and UniProt, as well as with manu-
ally curated peptide data. The database application was
developed to query the data using text and sequence sim-
ilarity search through a web-based user interface. The util-
ity of PepBank was demonstrated using different
examples of peptide sequences. The results show that the
database has valuable biological and medical applica-
tions. In the future, we plan to add other public sources of
peptide data, such as the peptide subset of the Molecular
Interaction database (MINT) [5], and other sources for
text mining, such as full-text journal articles. Also, in the
future we will apply machine learning techniques to
improve the accuracy of text mining to extract sequences.
In the next release, we plan to add the functionalities to
download the data in a standard format, such as PSI MI,
and to search the database for peptide motifs.
Availability and requirements
The database is freely available on http://pep
bank.mgh.harvard.edu/, and the text mining source code
(Peptide::Pubmed) is freely available above as well as on
CPAN http://www.cpan.org/.
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